The Cannabis Investing Podcast

With the U.S. economy reeling as a result of the COVID-19 pandemic, tax revenue is likely to have fallen precipitously for FY2020. Combine that with changing social attitudes towards cannabis and the upcoming U.S. election and you may just have the "perfect storm" for legalization on the federal level. Global X CEO Luis Berruga joins The Cannabis Investing Podcast to explain how his firm's ETF (POTX) provides investors the opportunity to capitalize on the potential for federal legalization. And even if federal legalization doesn't become a reality in 2021, Berruga still sees plenty of upside for publicly-traded cannabis stocks with increasing numbers of state likely to legalize. Show Notes2:30 - A most elegant piece of financial engineering: What drew Luis to the ETF space?6:00 - A Perfect Storm: Will COVID-19 economic pain finally provide the impetus for federally legal cannabis in the U.S.?10:00 - The upcoming U.S. election: What different potential outcomes are likely to say about the prospects for legalization12:30 - Growth potential without U.S. federal legalization?15:15 - A consumer staple: Will cannabis' strongest growth lever be on the recreational or medical side of the business?19:30 - Are today's cannabis industry leaders still likely to be leaders in a decade's time?24:00 - Under the hood: POTX holdings and indexing methodologyLearn more about your ad choices. Visit megaphone.fm/adchoices

Cannabis stocks are a good deal right now - don't be afraid to put more money in. That's what Ted Waller, esteemed Seeking Alpha contributor, 50 year market veteran and cannabis investor, says. We agree! We also discuss how to know when to pull the trigger on a stock, favoring the extraction model going forward (oils over flower), ETFs vs. stocks, MJ's dividend and Ted's top picks in the space.Learn more about your ad choices. Visit megaphone.fm/adchoices

Talk to most successful cannabis investors and one of their top picks is likely to be Trulieve, the leading medical cannabis company in Florida. The company boasts strong financial performance and profitability in an industry still suffering from a capital crunch and inexperienced executives. Kim Rivers, CEO of Trulieve, returns to the show to discuss the necessity of passing banking regulations, Covid legislation and lessons we can learn from prohibition and the Great Depression. We also cover the incredible catalyst that is edibles in Florida, moving into Massachusetts, uplisting to a major US exchange and choosing responsible growth.Learn more about your ad choices. Visit megaphone.fm/adchoices

Mike Donnelly is a former Navy SEAL who, with his wife Claudia, founded a hemp-derived CBD company focused on giving back to the veteran community. He joins Rena Sherbill to discuss the saturation of the market, why CBD is especially good for dogs and the wonders of cannabinoids. They also talk about building the American Dream, starting a 501(c)(3) for veterans and why no one's actually buying CBD from Amazon.Learn more about your ad choices. Visit megaphone.fm/adchoices

How do you know which cannabis stocks to buy? Nicholas Gastevich, co-owner of a family firm in Chicago that invested early in the Illinois cannabis space, helps guide us. Why he likes Green Thumb Industries, Cresco, and his top 4 picks in the sector. We also cover the recent Canopy/Acreage deal, iAnthus' debt, excessive executive compensation and being greedy with shareholder money. We also discuss why many management changes are overblown, adjusted EBITDA and Illinois' once promising social equity program model.Learn more about your ad choices. Visit megaphone.fm/adchoices

Uruguay was the first country to legalize cannabis and where Kevin Nafte and Andrea Krell, married co-founders of YVY Life Sciences, decided to plant their sustainable, organic cannabis company. They join Rena Sherbill to discuss why problematic banking for cannabis companies exists in Uruguay, what to expect this year from Latin America, and the benefits of having Facundo Garretón on board. They also cover having to del with regulatory roll out despite legalization, teaching cannabis cultivation to farmers, and the benefits of rich soil and agricultural innovation.Learn more about your ad choices. Visit megaphone.fm/adchoices

As the cannabis industry matures, investors are looking for companies that are either already profitable (only a couple fit the bill) or at least on the right path. Barry Fishman, CEO at Vivo Cannabis, talks to Rena Sherbill about their path to profitability, focusing on Canada, Germany and Australia and his view on the necessity of debt. We also cover what they look for in M&A targets, why they're not focusing on the US, social equity in the industry, and the challenges COVID brings.Learn more about your ad choices. Visit megaphone.fm/adchoices

Derek Du Chesne, President and Chief Growth Officer at Exactus, a company that recently pivoted into the hemp space, tells Rena Sherbill why he's looking forward to industry consolidation. We also discuss what's going to drive exponential growth in the hemp and cannabinoid industry, discovering how different cannabinoids affect us and why CBD is just the tip of the iceberg. Given his background in entertainment, we also discuss why making a movie is like creating a start up, hemp genetics and why genetics are a trust purchase. We also cover China, how it's substantially ahead in hemp manufacturing, but has very little related to cannabinoids, hemp farming methodology, and why high prices hinder industry growth.Learn more about your ad choices. Visit megaphone.fm/adchoices

Between hemp and marijuana, the difference is a legal one: how much THC is allowed in the plant. But it's all cannabis. Hemp has mostly been used for industry and nutrition, but that's changing. Morris Beegle joins Rena Sherbill to discuss the shift from industrial hemp to cannabinoid hemp and why the investment play is on the fiber and grain side. We also cover the potential and power of hemp and the various ingredients it can create throughout many diverse sectors.Learn more about your ad choices. Visit megaphone.fm/adchoices

What does it take to scale U.S. regional cannabis brands and do so profitably? Rena Sherbill talks to two regional cannabis brands, Aviv Hadar from Oregrown and Eric Ross and Ed Weidenfeld of District Cannabis and Phyto Management. One from the Pacific Northwest, in Oregon and one from the East Coast in Washington DC/Maryland. Their issues with MSOs, why one believes in vertical integration and the other doesn't. We also discuss why balance sheets are just as important as income statements, the mistaken emphasis on rapid growth over revenue or profit, the impact of 280E, and 'The Canada Scam'.Learn more about your ad choices. Visit megaphone.fm/adchoices